{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:02:19Z","timestamp":1786118539378,"version":"build-2736575974"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1097\/bor.0b013e328010c56b","type":"journal-article","created":{"date-parts":[[2006,11,29]],"date-time":"2006-11-29T08:56:07Z","timestamp":1164790567000},"page":"74-80","source":"Crossref","is-referenced-by-count":14,"title":["Autoimmune liver disease and rheumatic manifestations"],"prefix":"10.1097","volume":"19","author":[{"given":"Albert J","family":"Czaja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210128","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0065-2423(05)40004-9","article-title":"Autoantibodies in autoimmune liver disease","volume":"40","author":"Czaja","year":"2005","journal-title":"Adv Clin Chem"},{"key":"R2-13-20210128","first-page":"313","article-title":"Diverse manifestations and evolving treatments of autoimmune hepatitis","volume":"51","author":"Czaja","year":"2005","journal-title":"Minerva Gastroenterol Dietol"},{"key":"R3-13-20210128","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S1665-2681(19)32081-2","article-title":"Current concepts in autoimmune hepatitis","volume":"4","author":"Czaja","year":"2005","journal-title":"Ann Hepatol"},{"key":"R4-13-20210128","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/hep.20539","article-title":"Treatment challenges and investigational opportunities in autoimmune hepatitis","volume":"41","author":"Czaja","year":"2005","journal-title":"Hepatology"},{"key":"R5-13-20210128","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/ard.2002.001826","article-title":"Hepatic manifestations of autoimmune rheumatic diseases","volume":"63","author":"Abraham","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"R6-13-20210128","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2036.2005.02403.x","article-title":"Diagnosis and treatment of autoimmune hepatitis at age 65 and older","volume":"21","author":"Versyle","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"R7-13-20210128","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/hep.21074","article-title":"Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly","volume":"43","author":"Czaja","year":"2006","journal-title":"Hepatology"},{"key":"R8-13-20210128","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1440-1827.2005.01790.x","article-title":"Autoimmune hepatitis in primary Sjogren's syndrome: pathological study of the livers and labial salivary glands in 17 patients with primary Sjogren's syndrome","volume":"55","author":"Matsumoto","year":"2005","journal-title":"Pathol Int"},{"key":"R9-13-20210128","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1468-3083.2005.01321.x","article-title":"Systemic sclerosis\u2013polymyositis overlap syndrome accompanied by autoimmune hepatitis and sarcoidosis of mediastinal lymph nodes","volume":"20","author":"Lis-Swiety","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R10-13-20210128","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2169\/internalmedicine.44.335","article-title":"Felty's syndrome with chronic hepatitis and compatible autoimmune hepatitis: a case presentation","volume":"44","author":"Sema","year":"2005","journal-title":"Intern Med"},{"key":"R11-13-20210128","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1365-2036.2005.02686.x","article-title":"Anticyclic citrullinated peptide antibodies in type 1 autoimmune hepatitis","volume":"22","author":"Fusconi","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"R12-13-20210128","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/08916930600783348","article-title":"Frequency and significance of antibodies to cyclic citrullinated peptide in type 1 autoimmune hepatitis","volume":"39","author":"Montano-Loza","year":"2006","journal-title":"Autoimmunity"},{"key":"R13-13-20210128","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1002\/art.21419","article-title":"Regulation of anticyclic citrullinated peptide antibodies in rheumatoid arthritis. Contrasting effects of HLA-DR3 and the shared epitope alleles","volume":"52","author":"Irigoyen","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R14-13-20210128","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/ard.2005.041079","article-title":"Smoking is a risk factor for anti-CCP antibodies only in RA patients that carry HLA-DRB1 shared epitope alleles","volume":"65","author":"Linn-Rasker","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R15-13-20210128","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jaut.2005.01.016","article-title":"Prevalence and clinical significance of anticardiolipin antibodies in patients with type 1 autoimmune hepatitis","volume":"24","author":"Liaskos","year":"2005","journal-title":"J Autoimmun"},{"key":"R16-13-20210128","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1196\/annals.1361.043","article-title":"Clinical relevance of antiphospholipid antibodies in primary biliary cirrhosis","volume":"1051","author":"von Landenberg","year":"2005","journal-title":"Ann NY Acad Sci"},{"key":"R17-13-20210128","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ejim.2005.01.014","article-title":"Autoimmune hepatitis associated with antiphospholipid syndrome and ulcerative colitis [letter to the editor]","volume":"16","author":"Linares","year":"2005","journal-title":"Eur J Intern Med"},{"key":"R18-13-20210128","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/lt.20404","article-title":"Antibodies against cytokeratin 8\/18 in a patient with de novo autoimmune hepatitis after living-donor liver transplantation","volume":"11","author":"Inui","year":"2005","journal-title":"Liver Transpl"},{"key":"R19-13-20210128","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.autrev.2005.01.005","article-title":"T cell immunity in autoimmune hepatitis","volume":"4","author":"Ichiki","year":"2005","journal-title":"Autoimmun Rev"},{"key":"R20-13-20210128","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaut.2005.05.001","article-title":"Effect of CD4+CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis","volume":"25","author":"Longhi","year":"2005","journal-title":"J Autoimmun"},{"key":"R21-13-20210128","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.4049\/jimmunol.176.7.4484","article-title":"Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis","volume":"176","author":"Longhi","year":"2006","journal-title":"J Immunol"},{"key":"R22-13-20210128","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/hep.21123","article-title":"Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis","volume":"43","author":"Lan","year":"2006","journal-title":"Hepatology"},{"key":"R23-13-20210128","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/labinvest.3700246","article-title":"MHC-independent genetic regulation of liver damage in a mouse model of autoimmune hepatocellular injury","volume":"85","author":"Lin","year":"2005","journal-title":"Lab Invest"},{"key":"R24-13-20210128","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1440-1746.2005.03532.x","article-title":"Genetic association of vitamin D receptor polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in China","volume":"20","author":"Fan","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"key":"R25-13-20210128","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jpeds.2005.01.050","article-title":"Detection of autoimmune regulator gene mutations in children with type 2 autoimmune hepatitis and extrahepatic immune-mediated diseases","volume":"146","author":"Lankisch","year":"2005","journal-title":"J Pediatr"},{"key":"R26-13-20210128","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.hepres.2005.04.006","article-title":"C77G mutation in protein tyrosine phosphatase CD45 gene and autoimmune hepatitis","volume":"32","author":"Esteghamat","year":"2005","journal-title":"Hepatol Res"},{"key":"R27-13-20210128","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.3748\/wjg.v11.i18.2768","article-title":"Genetic association of cytokine polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese","volume":"11","author":"Fan","year":"2005","journal-title":"World J Gastroenterol"},{"key":"R29-13-20210128","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1478-3231.2006.01249.x","article-title":"Clinical and HLA phenotypes of type 1 autoimmune hepatitis in North America outside DR3 and DR4","volume":"26","author":"Czaja","year":"2006","journal-title":"Liver Int"},{"key":"R31-13-20210128","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/08916930500050285","article-title":"Shared autoimmunity: a concept for which the time has come","volume":"38","author":"Alarcon-Segovia","year":"2005","journal-title":"Autoimmunity"},{"key":"R32-13-20210128","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jhep.2005.11.037","article-title":"Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a foray across diagnostic boundaries [editorial]","volume":"44","author":"Czaja","year":"2006","journal-title":"J Hepatol"},{"key":"R33-13-20210128","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1007\/s10620-006-9336-5","article-title":"Thiopurine methyltransferase deficiency and azathioprine intolerance in autoimmune hepatitis","volume":"51","author":"Czaja","year":"2006","journal-title":"Dig Dis Sci"},{"key":"R34-13-20210128","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1478-3231.2005.01107.x","article-title":"Transplant immunosuppressive agents in nontransplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus","volume":"25","author":"Chatur","year":"2005","journal-title":"Liver Int"},{"key":"R35-13-20210128","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/j.1478-3231.2005.01122.x","article-title":"Budesonide in previously untreated autoimmune hepatitis","volume":"25","author":"Wiegand","year":"2005","journal-title":"Liver Int"},{"key":"R36-13-20210128","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1600-6143.2005.00801.x","article-title":"Rapamycin successfully treats posttransplant autoimmune hepatitis","volume":"5","author":"Kerkar","year":"2005","journal-title":"Am J Transpl"},{"key":"R37-13-20210128","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/00042737-200504000-00012","article-title":"Promising treatment of autoimmune hepatitis with 6-thioguanine after adverse events on azathioprine","volume":"17","author":"de Boer","year":"2005","journal-title":"Eur J Gastroenterol"},{"key":"R38-13-20210128","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/01.mcg.0000177260.72692.e8","article-title":"Empiric therapy of autoimmune hepatitis with mycophenolate mofetil: comparison with conventional treatment for refractory disease","volume":"39","author":"Czaja","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"R39-13-20210128","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1478-3231.2005.01123.x","article-title":"Use of mycophenolate mofetil in the treatment of autoimmune hepatitis [editorial]","volume":"25","author":"Oo","year":"2005","journal-title":"Liver Int"},{"key":"R40-13-20210128","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1365-2036.2005.02581.x","article-title":"On the limitation of 6-tioguaninenucleotide monitoring during tioguanine treatment","volume":"22","author":"de Boer","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"R41-13-20210128","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1136\/ard.2004.032821","article-title":"Autoimmune hepatitis associated with infliximab in a patient with psoriatic arthritis","volume":"64","author":"Germano","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R43-13-20210128","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10620-005-2472-5","article-title":"Impact of immunosuppressive treatment on liver fibrosis in autoimmune hepatitis","volume":"50","author":"Mohamadnejad","year":"2005","journal-title":"Dig Dis Sci"},{"key":"R44-13-20210128","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jhep.2005.06.006","article-title":"Persistent normalization of serum alanine aminotransferase levels improves the prognosis of type 1 autoimmune hepatitis","volume":"43","author":"Miyake","year":"2005","journal-title":"J Hepatol"},{"key":"R45-13-20210128","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1478-3231.2005.01141.x","article-title":"Autoimmune hepatitis type 1: safety and efficacy of prolonged medical therapy","volume":"25","author":"Seela","year":"2005","journal-title":"Liver Int"},{"key":"R46-13-20210128","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.semarthrit.2005.03.002","article-title":"Autoimmune hepatitis and pregnancy: a rheumatologist's dilemma","volume":"35","author":"Candia","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"R47-13-20210128","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1440-1827.2005.01886.x","article-title":"Postliver transplantation de novo hepatitis with overlap features","volume":"55","author":"Keaveny","year":"2005","journal-title":"Pathol Int"},{"key":"R48-13-20210128","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1055\/s-2005-916328","article-title":"Auxiliary partial orthotopic liver transplantation with de novo autoimmune hepatitis in the allograft and leftover primary biliary cirrhosis in the native liver","volume":"25","author":"Tsuji","year":"2005","journal-title":"Semin Liver Dis"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/BOR.0b013e328010c56b","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:00:30Z","timestamp":1786032030000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002281-200701000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0b013e328010c56b","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}